Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hisamitsu Pharmaceutical Co.,Inc.

https://global.hisamitsu/

Latest From Hisamitsu Pharmaceutical Co.,Inc.

BMS Hopes Turning Point Buyout Will Fare Better Than Roche’s Ignyta Acquisition

Bristol Myers Squibb thinks Turning Point’s ROS1/TRK inhibitor shows a best-in-class profile and potential to compete more successfully against Pfizer’s Xalkori than Roche’s Rozlytrek has.

M & A Cancer

Finance Watch: VC Mega-Rounds Are Alive And Well

Private Company Edition: Also, Catalio closed a $381m venture capital fund and OrbiMed’s SEC filings indicate it is in the process of raising $4.75bn across three new funds. Dianthus launched with $100m and Tubulis closed a $63m series B round.

Financing Innovation

ProQR Remains Confident In Pipeline After Sepofarsen Flop, Analysts Not So Much

The company is pinning hopes on its Usher syndrome and retinitis pigmentosa programs, but the disconnect between Phase I/II success and Phase II/III failure dented analysts’ enthusiasm.

Ophthalmic BioPharmaceutical

Finance Watch: Three Newly Public Companies Face Mixed Reception In Early Trading

Also, two more health care-focused SPACs went public, Centessa obtained up to $300m in debt, three new venture capital funds launched and Intergalactic debuted with a $75m series A round.

Financing Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
    • Drug Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • CRCC Media Co.,Ltd. (Fukuoka)
    • Saga City-Vision Co.,Ltd. (Saga)
    • Taiyo Co.,Ltd (Saga)
    • Kyudo Co.,Ltd (Saga)
    • Hisamitsu Agency Co.,Ltd. (Fukuoka)
    • Hisamitsu U.S., Inc.
    • Hisamitsu America, Inc.
    • Noven Pharmaceuticals, Inc.
    • Hisamitsu Farmaceutica do Brasil Ltda.
    • Hisamitsu UK Ltd.
    • Hisamitsu Italia S.r.l.
    • Hisamitsu Vietnam Pharmaceutical Co.,Ltd.
    • Hisamitsu Pharmaceutical(China)Co.,Ltd.
    • Hisamitsu Pharmaceutical Technology Consulting(Beijing) Co.,Ltd.
    • Hisamitsu Pharmaceutical (Hong Kong)Co.,Ltd.
    • PT. Hisamitsu Pharma Indonesia
UsernamePublicRestriction

Register